Central nervous system circuitry and peripheral neural sympathetic activity responsible for essential hypertension

Area of Science:

• Neuroscience
• Cardiovascular Physiology
• Pharmacology

Background:

• Essential hypertension (EH) is a prevalent cardiovascular disorder with complex pathophysiology.
• Existing research often overlooks the central nervous system (CNS) mechanisms driving EH.
• Understanding the neural circuitry linking CNS to peripheral autonomic dysfunction is crucial for EH management.

Purpose of the Study:

• To review the CNS circuitry involved in cardiovascular pathophysiology relevant to EH.
• To propose a hypothesis implicating specific noradrenergic and serotonergic nuclei in EH.
• To explore neuropharmacological therapeutic strategies targeting these CNS pathways.

Main Methods:

• Literature review focusing on CNS mechanisms in essential hypertension.
• Analysis of neurophysiological and neuropharmacological data.
• Postulation of a central hypothesis regarding specific brainstem nuclei.

Main Results:

• Essential hypertension may be linked to the dominance of the A5 noradrenergic (NA) nucleus + median raphe serotonergic (5-HT) nucleus.
• A less dominant (A6)-NA + dorsal raphe-5-HT nuclei binomial may be implicated in EH pathophysiology.
• Neuropharmacological therapy aimed at enhancing the (A6)-NA + dorsal raphe-5-HT circuitry showed promise.

Conclusions:

• The central nervous system plays a critical role in the pathophysiology of essential hypertension.
• A specific imbalance between noradrenergic and serotonergic nuclei in the brainstem is hypothesized to underlie EH.
• Targeting the (A6)-NA + dorsal raphe-5-HT circuitry represents a potential therapeutic avenue for essential hypertension.